L.p. Ii Fund Strategic Global Venbio

Affiliations

  • Large Shareholder at Checkmate Pharmaceuticals Inc. (CMPI), 2022-05-17
  • at Impel Neuropharma Inc (IMPL), 2021-04-29
  • at Alx Oncology Holdings Inc (ALXO), 2020-07-22
  • at Akero Therapeutics Inc. (AKRO), 2020-07-06
  • Large Shareholder at Menlo Therapeutics Inc. (MNLO), 2018-01-29
  • Large Shareholder at Apellis Pharmaceuticals Inc. (APLS), 2017-11-13
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
IMPL $15.00 450,000 $6,750,000.00 2,759,791 2021-04-27 Filing
CMPI $15.00 200,000 $3,000,000.00 3,673,374 2020-08-11 Filing
AKRO $16.00 250,000 $4,000,000.00 250,000 2019-06-24 Filing
MNLO $17.00 265,000 $4,505,000.00 265,000 2018-01-25 Filing
APLS $14.00 127,515 $1,785,210.00 3,579,305 2017-11-13 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CMPI $10.45 95,800 $1,001,100.42 2,155,930 2022-05-16 Filing
CMPI $10.45 35,850 $374,464.01 2,251,730 2022-05-13 Filing
CMPI $10.39 124,525 $1,294,312.85 2,287,580 2022-05-12 Filing
CMPI $10.38 17,700 $183,641.04 2,412,105 2022-05-11 Filing
CMPI $10.38 18,676 $193,869.95 2,429,805 2022-05-10 Filing